Found: 33
Select item for more details and to access through your institution.
Drug‐induced interstitial pneumonia after intravesical Bacillus Calmette‐Guerin administration for bladder cancer with scleroderma.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Recovery from prolonged thrombocytopenia in patients with TAFRO syndrome: case series and literature review.
- Published in:
- Modern Rheumatology Case Reports, 2020, v. 4, n. 2, p. 302, doi. 10.1080/24725625.2020.1717747
- By:
- Publication type:
- Article
LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activation.
- Published in:
- Scientific Reports, 2016, p. 25738, doi. 10.1038/srep25738
- By:
- Publication type:
- Article
Extensive RNA editing and possible double-stranded structures determining editing sites in the atpB transcripts of hornwort chloroplasts.
- Published in:
- Nucleic Acids Research, 1997, v. 25, n. 23, p. 4830, doi. 10.1093/nar/25.23.4830
- By:
- Publication type:
- Article
Proteomics-based identification of α-enolase as a tumor antigen in non-small lung cancer.
- Published in:
- Cancer Science, 2007, v. 98, n. 8, p. 1234, doi. 10.1111/j.1349-7006.2007.00509.x
- By:
- Publication type:
- Article
SLE stratification based on BAFF and IFN-I bioactivity for biologics and implications of BAFF produced by glomeruli in lupus nephritis.
- Published in:
- Rheumatology, 2023, v. 62, n. 5, p. 1988, doi. 10.1093/rheumatology/keac528
- By:
- Publication type:
- Article
Therapeutic effect of tocilizumab on two patients with polymyositis.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Therapeutic effect of tocilizumab on two patients with polymyositis.
- Published in:
- 2011
- By:
- Publication type:
- Letter
The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab.
- Published in:
- Rheumatology, 2010, v. 49, n. 12, p. 2408, doi. 10.1093/rheumatology/keq275
- By:
- Publication type:
- Article
Treatment of a patient with remitting seronegative, symmetrical synovitis with pitting oedema with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
- Published in:
- 2010
- By:
- Publication type:
- Letter
The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis.
- Published in:
- PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0162306
- By:
- Publication type:
- Article
Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for the treatment of autoimmune disorders.
- Published in:
- Drug Development Research, 2011, v. 72, n. 8, p. 717, doi. 10.1002/ddr.20480
- By:
- Publication type:
- Article
Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications.
- Published in:
- Arthritis & Rheumatology, 2015, v. 67, n. 6, p. 1481, doi. 10.1002/art.39086
- By:
- Publication type:
- Article
Cytokines Involved in the Pathogenesis of SSc and Problems in the Development of Anti-Cytokine Therapy.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 5, p. 1104, doi. 10.3390/cells10051104
- By:
- Publication type:
- Article
The proliferative activity levels of each immune cell population evaluated by mass cytometry are linked to the clinical phenotypes of systemic lupus erythematosus.
- Published in:
- International Immunology, 2023, v. 35, n. 1, p. 27, doi. 10.1093/intimm/dxac042
- By:
- Publication type:
- Article
Anti-receptor activator of nuclear factor κB ligand antibody treatment increases osteoclastogenesis-promoting IL-8 in patients with rheumatoid arthritis.
- Published in:
- International Immunology, 2019, v. 31, n. 5, p. 277, doi. 10.1093/intimm/dxz009
- By:
- Publication type:
- Article
Effect of Enzymatically Modified Isoquercitrin, a Flavonoid, on Symptoms of Japanese Cedar Pollinosis: A Randomized Double-Blind Placebo-Controlled Trial.
- Published in:
- International Archives of Allergy & Immunology, 2009, v. 149, n. 4, p. 359, doi. 10.1159/000205582
- By:
- Publication type:
- Article
Luteolin, a Flavonoid, Inhibits CD40 Ligand Expression by Activated Human Basophils.
- Published in:
- International Archives of Allergy & Immunology, 2006, v. 140, n. 2, p. 150, doi. 10.1159/000092554
- By:
- Publication type:
- Article
Flavonoids such as Luteolin, Fisetin and Apigenin Are Inhibitors of Interleukin-4 and Interleukin-13 Production by ActivatedHuman Basophils.
- Published in:
- International Archives of Allergy & Immunology, 2004, v. 134, n. 2, p. 135, doi. 10.1159/000078498
- By:
- Publication type:
- Article
Heating of the neck or elbows alleviates Raynaud's phenomenon but has different effects on different types of patients with systemic sclerosis.
- Published in:
- Modern Rheumatology, 2024, v. 34, n. 4, p. 750, doi. 10.1093/mr/road091
- By:
- Publication type:
- Article
Efficacy and safety of tocilizumab in Japanese patients with systemic sclerosis and associated interstitial lung disease: A subgroup analysis of a global, randomised, controlled Phase 3 trial.
- Published in:
- Modern Rheumatology, 2024, v. 34, n. 3, p. 530, doi. 10.1093/mr/road068
- By:
- Publication type:
- Article
Arm heating to relieve Raynaud's phenomenon in systemic sclerosis: A single-arm multicentre prospective clinical trial.
- Published in:
- Modern Rheumatology, 2023, v. 33, n. 5, p. 968, doi. 10.1093/mr/roac116
- By:
- Publication type:
- Article
Proximal heat stress up-regulates angiopoietin-1 in fingers and reduces the severity of Raynaud's phenomenon in systemic sclerosis: a single-centre pilot study.
- Published in:
- Modern Rheumatology, 2022, v. 32, n. 2, p. 351, doi. 10.1093/mr/roab014
- By:
- Publication type:
- Article
The benefits and prospects of interleukin-6 inhibitor on systemic sclerosis.
- Published in:
- Modern Rheumatology, 2019, v. 29, n. 2, p. 294, doi. 10.1080/14397595.2018.1559909
- By:
- Publication type:
- Article
Add-on tocilizumab versus conventional treatment for systemic sclerosis, and cytokine analysis to identify an endotype to tocilizumab therapy.
- Published in:
- Modern Rheumatology, 2019, v. 29, n. 1, p. 134, doi. 10.1080/14397595.2018.1452178
- By:
- Publication type:
- Article
Expansion of range of joint motion following treatment of systemic sclerosis with tocilizumab.
- Published in:
- Modern Rheumatology, 2015, v. 25, n. 1, p. 134, doi. 10.3109/14397595.2013.874749
- By:
- Publication type:
- Article
Expansion of range of joint motion following treatment of systemic sclerosis with tocilizumab.
- Published in:
- Modern Rheumatology, 2013, v. 23, n. 2, p. 1, doi. 10.1007/s10165-013-0855-6
- By:
- Publication type:
- Article
A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
- Published in:
- Modern Rheumatology, 2012, v. 22, n. 2, p. 298, doi. 10.3109/s10165-011-0497-5
- By:
- Publication type:
- Article
Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab.
- Published in:
- Modern Rheumatology, 2011, v. 21, n. 4, p. 420, doi. 10.3109/s10165-010-0411-6
- By:
- Publication type:
- Article
Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorated clinical symptoms and MRI findings of a patient with ankylosing spondylitis.
- Published in:
- Modern Rheumatology, 2011, v. 21, n. 4, p. 436, doi. 10.3109/s10165-011-0416-9
- By:
- Publication type:
- Article
Minimal influence of tocilizumab on IFN-γ synthesis by tuberculosis antigens.
- Published in:
- Modern Rheumatology, 2010, v. 20, n. 2, p. 130, doi. 10.3109/s10165-009-0243-4
- By:
- Publication type:
- Article
Imatinib mesylate inhibited rat adjuvant arthritis and PDGF-dependent growth of synovial fibroblast via interference with the Akt signaling pathway.
- Published in:
- Modern Rheumatology, 2009, v. 19, n. 5, p. 522, doi. 10.3109/s10165-009-0193-x
- By:
- Publication type:
- Article
A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosus.
- Published in:
- Modern Rheumatology, 2007, v. 17, n. 3, p. 191, doi. 10.3109/s10165-007-0565-z
- By:
- Publication type:
- Article